-
Featured
Coronary Artery Disease: Pathways and Subtypes
Precision medicine can help answer whether or not current heart disease treatment paradigms optimally address genetic heterogeneity.
-
Featured
Hope for High-risk Coronary Artery Patients
Many patients with complex CAD are high-risk and ineligible for surgical treatment. Alternative and advanced interventions at Mass General are proving to be effective.
-
Featured
Coronary Artery Disease - Reporting & Data System (CAD-RADS)
Massachusetts General Hospital clinicians discuss a male age 55 that presents with left sided chest pain and has a history of hypertension and hyperlipidemia.
-
Newly Identified Genes Linked to Coronary Artery Calcification
Hanna Barnes, MD, Christian Lino Cardenas, PhD, PharmD, Rajeev Malhotra, MD, and colleagues add to the understanding of the genetic basis of coronary artery calcification by identifying 43 candidate genes at 11 chromosomal locations and demonstrating effects on cellular reprogramming leading to vascular calcification.
-
CAD Prevalent in Patients With Type 2 MI but Usually Non-obstructive
Cian P. McCarthy, MBBCh, BAO, SM, James L. Januzzi, Jr., MD, and colleagues found in a prospective study that coronary artery disease affected 92% of patients with type 2 myocardial infarction, but despite a large overall burden of coronary plaque, 74% did not have hemodynamically significant focal stenosis.
-
Women's Heart Health Program Aims to Reduce Disparities
A pioneering Massachusetts General Hospital clinical care, research, and education program aims to improve outcomes from cardiovascular disease in women.
Coronary Artery Disease Contributors
-
Douglas E. Drachman, MD
Director, Education, Corrigan Minehan Heart Center, Director, Interventional Cardiology Fellowship Program, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
What to Expect at the ACC.23 Together With WCC: Q&A With Dr. Douglas Drachman -
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive -
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction -
James Louis Januzzi, MD
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital, Hutter Family Professor of Medicine in the Field of Cardiology, Harvard Medical School
Recent Article
Cardiorenal Biomarkers Predict Major Complications in Patients With Type 2 Diabetes and Chronic Kidney Disease -
Malissa J. Wood, MD
Co-Director, Corrigan Women's Heart Health Program
Recent Article
Review: Does Patient–Physician Gender Concordance Influence Patient Perceptions or Outcomes?